Cargando…
Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area
We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was <0.5%, which suggests that early lo...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450245/ https://www.ncbi.nlm.nih.gov/pubmed/32741409 http://dx.doi.org/10.1017/ice.2020.398 |
_version_ | 1783574777501319168 |
---|---|
author | Lewis, Sarah S. Smith, Becky A. Akinboyo, Ibukunoluwa C. Seidelman, Jessica Wolfe, Cameron Kirk, Allan B. Martin, Gavin Denny, Thomas Lobaugh, Bruce Rehder, Catherine Cardona, Diana Lee, Mark J. Polage, Christopher R. Datto, Michael B. |
author_facet | Lewis, Sarah S. Smith, Becky A. Akinboyo, Ibukunoluwa C. Seidelman, Jessica Wolfe, Cameron Kirk, Allan B. Martin, Gavin Denny, Thomas Lobaugh, Bruce Rehder, Catherine Cardona, Diana Lee, Mark J. Polage, Christopher R. Datto, Michael B. |
author_sort | Lewis, Sarah S. |
collection | PubMed |
description | We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was <0.5%, which suggests that early local public health interventions were successful. Although our protocol was resource intensive, it prevented exposures to healthcare team members. |
format | Online Article Text |
id | pubmed-7450245 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-74502452020-08-27 Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area Lewis, Sarah S. Smith, Becky A. Akinboyo, Ibukunoluwa C. Seidelman, Jessica Wolfe, Cameron Kirk, Allan B. Martin, Gavin Denny, Thomas Lobaugh, Bruce Rehder, Catherine Cardona, Diana Lee, Mark J. Polage, Christopher R. Datto, Michael B. Infect Control Hosp Epidemiol Concise Communication We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was <0.5%, which suggests that early local public health interventions were successful. Although our protocol was resource intensive, it prevented exposures to healthcare team members. Cambridge University Press 2020-08-03 /pmc/articles/PMC7450245/ /pubmed/32741409 http://dx.doi.org/10.1017/ice.2020.398 Text en © The Society for Healthcare Epidemiology of America 2020 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Concise Communication Lewis, Sarah S. Smith, Becky A. Akinboyo, Ibukunoluwa C. Seidelman, Jessica Wolfe, Cameron Kirk, Allan B. Martin, Gavin Denny, Thomas Lobaugh, Bruce Rehder, Catherine Cardona, Diana Lee, Mark J. Polage, Christopher R. Datto, Michael B. Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area |
title | Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area |
title_full | Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area |
title_fullStr | Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area |
title_full_unstemmed | Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area |
title_short | Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area |
title_sort | early experience with universal preprocedural testing for sars-cov-2 in a relatively low-prevalence area |
topic | Concise Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450245/ https://www.ncbi.nlm.nih.gov/pubmed/32741409 http://dx.doi.org/10.1017/ice.2020.398 |
work_keys_str_mv | AT lewissarahs earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea AT smithbeckya earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea AT akinboyoibukunoluwac earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea AT seidelmanjessica earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea AT wolfecameron earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea AT kirkallanb earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea AT martingavin earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea AT dennythomas earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea AT lobaughbruce earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea AT rehdercatherine earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea AT cardonadiana earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea AT leemarkj earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea AT polagechristopherr earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea AT dattomichaelb earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea |